Jame Abraham
Impact in
- Cancer Research top 1%
- Breast Cancer Treatment Studies
- Cancer, Hypoxia, and Metabolism
- Oncology top 1%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
Papers in
- Oncology 80
- HER2/EGFR in Cancer Research 28
- Cancer Treatment and Pharmacology 21
- Cancer Risks and Factors 10
-
- Breast Cancer Treatment Studies 18
- Co-authors
- Tito Fojo (9 shared papers)Gerald M. Higa (5 shared papers)Megan Lynn Kruse (10 shared papers)Alberto J. Montero (9 shared papers)Siddharth Kunte (2 shared papers)Sobha Kurian (5 shared papers)Susan E. Bates (6 shared papers)Bradford J. Wood (2 shared papers)
- Journals
- Expert Review of Anticancer Therapy (9 papers)Journal of the National Comprehensive Cancer Network (8 papers)Breast Cancer Research and Treatment (7 papers)Clinical Breast Cancer (6 papers)Journal of Oncology Practice (5 papers)
- Partner nations
- United StatesIndiaUnited Kingdom
In The Last Decade
Jame Abraham
140 papers receiving 7.9k citations
Jame Abraham's Hit Papers
Peers
Comparison fields: 5 of 141
- Cancer Research 1.7k
- Oncology 2.8k
- Pulmonary and Respiratory Medicine 1.3k
- Radiology, Nuclear Medicine and Imaging 860
- Genetics 300
Countries citing papers authored by Jame Abraham
This map shows the geographic impact of Jame Abraham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jame Abraham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jame Abraham more than expected).
Fields of papers citing papers by Jame Abraham
This network shows the impact of papers produced by Jame Abraham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jame Abraham. The network helps show where Jame Abraham may publish in the future.
Co-authors
The 25 scholars most cited alongside Jame Abraham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 147 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology Hit paper breakdown → | 2020 | 1325 |
| 2 | Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology Hit paper breakdown → | 2022 | 674 |
| 3 | Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2017 | 461 |
| 4 | NCCN Guidelines® Insights: Breast Cancer, Version 4.2023 Hit paper breakdown → | 2023 | 317 |
| 5 | Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology Hit paper breakdown → | 2024 | 298 |
| 6 | 2010 | 293 | |
| 7 | Association of Peritumoral Radiomics With Tumor Biology and Pathologic Response to Preoperative Targeted Therapy for HER2 (ERBB2) –Positive Breast Cancer Hit paper breakdown → | 2019 | 268 |
| 8 | 2019 | 247 | |
| 9 | NCCN Guidelines® Insights: Breast Cancer, Version 4.2021 Hit paper breakdown → | 2021 | 239 |
| 10 | Association of Bariatric Surgery With Cancer Risk and Mortality in Adults With Obesity Hit paper breakdown → | 2022 | 231 |
| 11 | 2003 | 213 | |
| 12 | 2008 | 197 | |
| 13 | 2019 | 172 | |
| 14 | 2020 | 171 | |
| 15 | 2017 | 161 | |
| 16 | 2003 | 120 | |
| 17 | 2015 | 113 | |
| 18 | Increased 99mTc-sestamibi accumulation in normal liver and drug-resistant tumors after the administration of the glycoprotein inhibitor, XR9576. | 2003 | 112 |
| 19 | 2019 | 111 | |
| 20 | 2007 | 108 |
About Jame Abraham
Jame Abraham is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Hematology, having authored 147 papers that have together received 8.1k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (28 papers), Cancer Treatment and Pharmacology (21 papers), Advanced Breast Cancer Therapies (18 papers), Breast Cancer Treatment Studies (18 papers), Cancer Risks and Factors (10 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Adrenal and Paraganglionic Tumors (5 papers) and Chronic Lymphocytic Leukemia Research (5 papers). The work is most often cited by research in Cancer Research (1.7k citations), Oncology (2.8k citations), Pulmonary and Respiratory Medicine (1.3k citations), Radiology, Nuclear Medicine and Imaging (860 citations) and Genetics (300 citations). Jame Abraham has collaborated with scholars based in United States, India and United Kingdom. Frequent co-authors include Tito Fojo, Gerald M. Higa, Megan Lynn Kruse, Alberto J. Montero, Siddharth Kunte, Sobha Kurian, Susan E. Bates, Bradford J. Wood, H. Richard Alexander and Alvin Howard Moss. Their work appears in journals such as Expert Review of Anticancer Therapy, Journal of the National Comprehensive Cancer Network, Breast Cancer Research and Treatment, Clinical Breast Cancer and Journal of Oncology Practice.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.